-
Mashup Score: 0
WASHINGTON — An app allowing family members of ICU patients to virtually report care needs to ICU clinicians lowered the number of unmet needs, according to research presented at the American Thoracic Society International Conference.“This trial provides compelling evidence for an easily replicable, intensivist-delivered, ‘primary palliative care’ intervention focused on
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
WASHINGTON — For patients with new moderate to severe obstructive sleep apnea, mandibular advancement device therapy reduced disorder severity, according to an abstract presented at the American Thoracic Society International Conference.“Continuous positive airway pressure (CPAP) is often recommended as first-line treatment option for patients with moderate to severe obstructive sleep
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
#ATS2023: After 3 months of treatment with a mandibular advancement device, researchers observed an overall #AHI score of 9.1 events per hour, which was significantly lower than the baseline overall AHI score of 27.2 events per hour. https://t.co/9pko0V9brb
-
-
Mashup Score: 0
WASHINGTON — For patients with new moderate to severe obstructive sleep apnea, mandibular advancement device therapy reduced disorder severity, according to an abstract presented at the American Thoracic Society International Conference.“Continuous positive airway pressure (CPAP) is often recommended as first-line treatment option for patients with moderate to severe obstructive sleep
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Presented at #ATS2023: For patients with new moderate to severe obstructive sleep apnea (#OSA), mandibular advancement device therapy reduced disorder severity. @atscommunity https://t.co/9pko0V9brb
-
-
Mashup Score: 0
WASHINGTON — An app allowing family members of ICU patients to virtually report care needs to ICU clinicians lowered the number of unmet needs, according to research presented at the American Thoracic Society International Conference.“This trial provides compelling evidence for an easily replicable, intensivist-delivered, ‘primary palliative care’ intervention focused on
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Presented at #ATS2023: An app allowing family members of #ICU patients to virtually report care needs to ICU clinicians lowered the number of unmet needs. https://t.co/v3dQqQqixh
-
-
Mashup Score: 0Ziritaxestat fails to improve lung function in patients with idiopathic pulmonary fibrosis - 11 month(s) ago
WASHINGTON — In patients with idiopathic pulmonary fibrosis, yearly lung function decline rates did not improve with two different dosages of ziritaxestat, according to an American Thoracic Society International Conference presentation.“Unfortunately, ziritaxestat did not improve clinical outcomes compared with placebo in patients with IPF receiving standard of care,” Toby M.
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
"Even though we haven’t got a new drug to report for #IPF patients, we have learned a lot about delivering phase 3 trials going forward," Toby M. Maher, MD, PhD, at @KeckMedUSC, said during an #ATS2023 presentation. https://t.co/tLtUcfM9RO
-
-
Mashup Score: 0Ziritaxestat fails to improve lung function in patients with idiopathic pulmonary fibrosis - 11 month(s) ago
WASHINGTON — In patients with idiopathic pulmonary fibrosis, yearly lung function decline rates did not improve with two different dosages of ziritaxestat, according to an American Thoracic Society International Conference presentation.“Unfortunately, ziritaxestat did not improve clinical outcomes compared with placebo in patients with IPF receiving standard of care,” Toby M.
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Presented at #ATS2023: In patients with #IPF, yearly #lung function decline rates did not improve with two different dosages of ziritaxestat. @atscommunity https://t.co/tLtUcfM9RO
-
-
Mashup Score: 0Pulse oximeters may misjudge sleep apnea severity in Black patients - 11 month(s) ago
WASHINGTON — Black patients had decreased desaturation sensitivity during sleep recorded by pulse oximeters, according to research presented at the American Thoracic Society International Conference.“Our findings suggest that these measurement problems may lead to underestimation of the severity of OSA in Black individuals,” Ali Azarbarzin, PhD, assistant professor of medicine
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Presented at #ATS2023: Black patients had decreased #desaturation sensitivity during sleep recorded by pulse #oximeters. @atscommunity https://t.co/FLvOtbt5GU
-
-
Mashup Score: 1Interstitial Lung Disease Highlights From ATS 2023 - 11 month(s) ago
New research from ATS 2023 demonstrates how artificial intelligence may improve diagnosis and prognosis in ILD, and a new therapy shows efficacy for a major comorbidity in this condition.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
New research from #ATS2023 demonstrates how artificial intelligence may improve diagnosis and prognosis in ILD, and a new therapy shows efficacy for a major comorbidity in this condition. https://t.co/zhjZo3wCwq https://t.co/Gk4cGy3foX
-
-
Mashup Score: 0Monitoring advised for children, teens with Down syndrome using positive airway pressure - 11 month(s) ago
WASHINGTON — Positive airway pressure device compliance went down 90 days after a clinic visit among patients with Down syndrome, according to an abstract presented at the American Thoracic Society International Conference.“Obstructive sleep apnea (OSA) is highly prevalent in individuals with Down syndrome,” Rakesh Bhattacharjee, MD, associate professor of pediatrics at
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
#ATS2023: At day 30, researchers found that positive airway pressure device compliance was “modest” at 56.7%, but when checked again at the 90-day mark, it went down to 34.4%. https://t.co/Ul6XFe8TOX
-
-
Mashup Score: 0Monitoring advised for children, teens with Down syndrome using positive airway pressure - 11 month(s) ago
WASHINGTON — Positive airway pressure device compliance went down 90 days after a clinic visit among patients with Down syndrome, according to an abstract presented at the American Thoracic Society International Conference.“Obstructive sleep apnea (OSA) is highly prevalent in individuals with Down syndrome,” Rakesh Bhattacharjee, MD, associate professor of pediatrics at
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Presented at #ATS2023: Positive airway pressure device compliance went down 90 days after a clinic visit among patients with Down syndrome. @atscommunity https://t.co/Ul6XFe8TOX
-
#ATS2023: From day 1 to day 3, more improvement in Needs at the End-of-Life Screening Tool (NEST) scores were found in the group receiving the #ICUconnect app intervention than the group receiving usual care (estimated mean between group difference, –6.7). https://t.co/v3dQqQqixh